老年人原发性肝癌综合治疗的研究进展

摘要

原发性肝癌(PHC)严重威胁人们的生命健康.随着中国逐步进入老龄化社会,60岁以上老年人已占社会总人口的13％,肝癌在老年人中的发病率亦逐渐增加.目前肝癌在我国恶性肿瘤中的发病居第三,老年肝癌患者占总患者数的47.5％.由于老年肝癌患者常伴有心脑血管疾病、糖尿病等合并症,其治疗更加困难.因此,采用多种疗法的综合治疗模式,提高患者的生活质量,延长患者生存时间,已成为目前肝癌治疗的关键问题.本文就目前老年肝癌患者的临床综合治疗研究进展作一综述.%Primary hepatocellular carcinoma (PHC) is a common malignant tumor in our country,which seriously threatens people's health.As China gradually enters the aging society,the elderly over 60 years old take up for 13％ of the total population.The incidence of PHC in the elderly is increasing at the same time.At present,the incidence of hepatocarcinoma in China is the third highest among malignant tumors,and 47.5％ of the patietns are elderly patients.As the elderly patients are often accompanied by cardiovascular and cerebrovascular diseases,diabetes and other complications,making the treatment of PHC in the elderly become much more difficult.Therefore,adopting a comprehensive treatment model of multiple therapies to improve the quality of life of patients and prolong the survival time of patients,has become the key issue.This article reviews the current progress in the clinical treatment of PHC in the elderly.